Subtype switching in breast cancer brain metastases: a multicenter analysis

BACKGROUND: Breast cancer (BC) brain metastases (BM) can have discordant hormonal or human epidermal growth factor receptor 2 (HER2) expression compared with corresponding primary tumors. This study aimed to describe incidence, predictors, and survival outcomes of discordant receptors and associated...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Hulsbergen, Alexander F C, Claes, An, Kavouridis, Vasileios K, Ansaripour, Ali, Nogarede, Claudine, Hughes, Melissa E, Smith, Timothy R, Brastianos, Priscilla K, Verhoeff, Joost J C, Lin, Nancy U, Broekman, Marike L D
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Clinical Investigations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7471502/
https://ncbi.nlm.nih.gov/pubmed/31970416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa013
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares